Susquehanna International Group’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $197K | Sell |
26,500
-64,300
| -71% | -$677K | ﹤0.01% | 11729 |
|
|
2025
Q4 | $1.07M | Sell |
90,800
-33,300
| -27% | -$359K | ﹤0.01% | 7032 |
|
|
2025
Q3 | $958K | Buy |
124,100
+59,400
| +92% | +$416K | ﹤0.01% | 7465 |
|
|
2025
Q2 | $473K | Buy |
64,700
+38,300
| +145% | +$309K | ﹤0.01% | 9300 |
|
|
2025
Q1 | $251K | Buy |
26,400
+13,400
| +103% | +$167K | ﹤0.01% | 10469 |
|
|
2024
Q4 | $214K | Sell |
13,000
-38,200
| -75% | -$593K | ﹤0.01% | 10585 |
|
|
2024
Q3 | $755K | Sell |
51,200
-32,200
| -39% | -$504K | ﹤0.01% | 7472 |
|
|
2024
Q2 | $1.16M | Sell |
83,400
-72,700
| -47% | -$1.03M | ﹤0.01% | 6245 |
|
|
2024
Q1 | $2.45M | Sell |
156,100
-41,900
| -21% | -$647K | ﹤0.01% | 4900 |
|
|
2023
Q4 | $3.2M | Buy |
198,000
+134,900
| +214% | +$2.21M | ﹤0.01% | 4457 |
|
|
2023
Q3 | $776K | Buy |
63,100
+46,200
| +273% | +$687K | ﹤0.01% | 7211 |
|
|
2023
Q2 | $272K | Sell |
16,900
-8,900
| -34% | -$147K | ﹤0.01% | 9641 |
|
|
2023
Q1 | $449K | Sell |
25,800
-15,300
| -37% | -$218K | ﹤0.01% | 8827 |
|
|
2022
Q4 | $380K | Sell |
41,100
-24,700
| -38% | -$230K | ﹤0.01% | 8527 |
|
|
2022
Q3 | $567K | Sell |
65,800
-30,300
| -32% | -$301K | ﹤0.01% | 8156 |
|
|
2022
Q2 | $783K | Buy |
96,100
+78,200
| +437% | +$747K | ﹤0.01% | 7131 |
|
|
2022
Q1 | $217K | Sell |
17,900
-7,100
| -28% | -$149K | ﹤0.01% | 11042 |
|
|
2021
Q4 | $853K | Sell |
25,000
-47,800
| -66% | -$1.87M | ﹤0.01% | 7720 |
|
|
2021
Q3 | $3.51M | Buy |
72,800
+22,300
| +44% | +$1.03M | ﹤0.01% | 4618 |
|
|
2021
Q2 | $2.28M | Sell |
50,500
-7,200
| -12% | -$319K | ﹤0.01% | 5618 |
|
|
2021
Q1 | $2.78M | Buy |
57,700
+41,100
| +248% | +$2.14M | ﹤0.01% | 5134 |
|
|
2020
Q4 | $894K | Sell |
16,600
-16,000
| -49% | -$723K | ﹤0.01% | 6969 |
|
|
2020
Q3 | $1.2M | Buy |
32,600
+8,500
| +35% | +$316K | ﹤0.01% | 5672 |
|
|
2020
Q2 | $747K | Sell |
24,100
-68,000
| -74% | -$1.88M | ﹤0.01% | 6533 |
|
|
2020
Q1 | $2.54M | Buy |
92,100
+46,200
| +101% | +$1.38M | ﹤0.01% | 3551 |
|
|
2019
Q4 | $1.34M | Buy |
45,900
+15,900
| +53% | +$379K | ﹤0.01% | 4985 |
|
|
2019
Q3 | $574K | Sell |
30,000
-2,200
| -7% | -$51.6K | ﹤0.01% | 6984 |
|
|
2019
Q2 | $706K | Buy |
32,200
+2,800
| +10% | +$61.4K | ﹤0.01% | 6491 |
|
|
2019
Q1 | $602K | Buy |
+29,400
| New | +$511K | ﹤0.01% | 5924 |
|
|
2016
Q4 | – | Sell |
-12,900
| Closed | -$106K | – | 9937 |
|
|
2016
Q3 | $106K | Buy |
12,900
+200
| +2% | +$1.68K | ﹤0.01% | 7914 |
|
|
2016
Q2 | $102K | Sell |
12,700
-10,200
| -45% | -$81.8K | ﹤0.01% | 8014 |
|
|
2016
Q1 | $154K | Buy |
22,900
+1,300
| +6% | +$8.55K | ﹤0.01% | 8189 |
|
|
2015
Q4 | $170K | Buy |
+21,600
| New | +$158K | ﹤0.01% | 8549 |
|
|
2014
Q4 | – | Sell |
-11,600
| Closed | -$60K | – | 9942 |
|
|
2014
Q3 | $60K | Sell |
11,600
-1,400
| -11% | -$7.19K | ﹤0.01% | 9187 |
|
|
2014
Q2 | $43K | Buy |
13,000
+2,700
| +26% | +$8.97K | ﹤0.01% | 9610 |
|
|
2014
Q1 | $36K | Buy |
+10,300
| New | +$38.6K | ﹤0.01% | 8745 |
|
Other funds holding NEO
FLAM
GF
VPM
VCM
B
Susquehanna International Group's NEO Position: Q1 2026 in Review
Susquehanna International Group increased its NeoGenomics (NEO) stake by 230% in Q1 2026, buying an estimated $348K and bringing the position to 47,452 shares worth $352K. The position accounts for ﹤0.01% of the portfolio, ranked #10518.
Susquehanna International Group first reported a position in NEO in Q4 2013 and has held it in 37 quarters since. The position peaked at $5.23M in Q4 2020. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.
- Susquehanna International Group held 47,452 shares of NeoGenomics worth $352K as of Q1 2026.
- Susquehanna International Group bought 33,082 NeoGenomics shares in Q1 2026, an estimated $348K.
- NeoGenomics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #10518 holding.
- Susquehanna International Group first reported a position in NeoGenomics in Q4 2013 and has held it in 37 quarters since.
- Susquehanna International Group's NeoGenomics position peaked at $5.23M in Q4 2020.
- 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.